🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Celebramos el día Mundial del Riñón con una carrera-caminata y realizamos la feria de la salud renal, con áreas de detección temprana, psiconefrologia, donación - trasplante y más!! Nefrología CMIT #WorldKidneyDay2025 #SociedadDeNefrologiaMexiquense

#RiskFactors for Disease Progression for Adults and Children With #MembranousNephropathy in the Cure #Glomerulonephropathy Network (CureGN) #VisualAbstract by Dr Priti MD,FASN🇮🇳 (प्रिति) kireports.org/article/S2468-…

🚨4th CMV Guidelines Are Now Available! 🚨 This updated international consensus—developed by leading CMV experts—reflects major advances in CMV diagnostics, prevention, treatment, and surveillance. Don't miss this must-read guidance! See the guidelines

Intravenous albumin is generally safe for most patients. However, its potential harms may be unknown. Given safety and cost concerns, authors of a recent #Perspective recommend that for most patients, use of intravenous albumin should adhere to ICTMG recommendations.

Gestión de la clínica de diálisis peritoneal, métricas de calidad del programa. Colegio de Nefrólogos de México A.C.

Muy buena imagen de resumen de los blancos terapéuticos de fármacos en nefrología y trasplante renal 🎯 👌🏻👌🏻

Post-transplant Diarrhea ca. 2021 from AJKD Samira Farouk, MD, MSCR Matthew Sparks, MD Krunal Amin #Nephpearls 👉 pubmed.ncbi.nlm.nih.gov/34303438/

New systematic review: What do adults on the kidney transplant waitlist think about extended criteria and increased viral risk donor offers? @TXPforAll #KidneyTransplantation tinyurl.com/3rxxmyk5

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application CREDENCE, DAPA-CKD, EMPA-KIDNEY, and FLOW, have demonstrated their efficacy in preserving kidney function and reducing adverse outcomes e-dmj.org/journal/view.p…

Kidneys from donors with acute kidney injury requiring dialysis (AKI-RRT) can be safely transplanted with outcomes comparable to AKI donors not on dialysis. Careful selection expands the donor pool without compromising graft survival. UC Davis #TXPforAll tinyurl.com/mr3njaf3

Ojo aquí 🤓

Association of #PulmonaryHypertension With Outcomes in #KidneyTransplant Recipients #VisualAbstract by Dr P S Vali kireports.org/article/S2468-…

#womeninnephrology 🫶🏼🫘👩🏻‍⚕️

Anti #Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary #MembranousNephropathy #VisualAbstract by Susan Thanabalasingam kireports.org/article/S2468-… Marco Allinovi

🚨 #TMA isn’t always what it seems! From 💊drugs to 🤰pregnancy, 🚑transplant to 📈HTN crisis—secondary TMA has many triggers. But many share a 🔥culprit: complement activation 🛡️Is C5 inhibition the game-changer? 📚doi.org/10.1093/ndt/gf… #NephTwitter #AKI #Nephrology #MedEd

Urinary rituximab loss and rate of treatment failure in membranous nephropathy doi.org/10.1093/ndt/gf…

🤓🫘

C3 glomerulopathy ▫️It presents with hematuria, varying degrees of proteinuria and renal failure ▫️Recurrence:60–90% ▫️>50%:ESKD within 10 yrs of diagnosis ▫️Eculizumab (limited success) ▫️RTX and plasma exchange are alternative ▫️Iptacopan and Pegcetocoplan most promising

¿Vas al Congreso SLANH 2025? No te pierdas esta experiencia única, ingresa a cursoagua.slanh.net para más información e inscripciones. ¡Te esperamos en Guayaquil!

Kidney transplant recipients with graft loss face major unmet care needs. This qualitative study highlights 6 key areas—from expectation setting to psychosocial support—where a patient-centered approach can improve outcomes. #TXPforAll #Transplantation tinyurl.com/mrfnp86d